Information portal on various topics of management of public resources of the Portuguese State

Project sheet

Name

Assistant Professor and IBB chair in Biomaterials, Nanotechnology and Regenerative Medicine

Total project amount

123,39 thousand €

Amount paid

0 €

Non-refundable funding

123,39 thousand €

Loan funding

0 €

Start date

01.02.2025

Expected end date

31.03.2026

Dimension

Resilience

Component

Qualifications and Skills

Investment

Science Plus Training

Operation code

02/C06-i06/2024.P2023.14864.TENURE.002

Summary

The scientific area of Biomaterials, Nanotechnology, and Regenerative Medicine (BNMR) of DBE integrates a set of technologies and tools which have as a common point the controlled interaction, at the micro and nanoscale, of complex constructs with biomolecules, cells and tissues. High impact applications in biotechnology and medicine are the goal, in particular in the development of novel strategies for  biodiagnostics  and  regenerative medicine . This area is organized into four Thematic Areasi)  Biomaterials  are primarily used for medical applications, but they are also used as scaffolds to grow cells in culture, to assay for blood proteins in the clinical laboratory, in processing biomolecules in biotechnology, in diagnostic gene arrays, and for investigational cell-based "biochips."ii)  Nanotechnology  is the understanding and control of matter at dimensions between approximately 1 and 100 nanometers, where unique phenomena enable novel applications.iii)  Nanobiotechnology  consists of the application of nanotechnology concepts to biological sciences, in lab-on-a-chip systems, novel biosensors, nanoparticles for drug delivery, surface functionalization, etc.iv)  Regenerative Medicine  is focused on the repair, replacement or regeneration of cells, tissues, or organs to restore impaired function resulting from any cause, including congenital defects, disease, trauma and ageing. It uses a combination of several converging technological approaches and moves beyond traditional transplantation and replacement therapies.The BNMR scientific area considers it essential to hire scientifically knowledgeable, technically skilled, and innovative engineers/scientists in these emerging research topics. By attracting new expertise on stem cell culture engineering, on organs-on-a-chip, or on biomaterials with an emphasis on the interface between the biomaterial and the living cells and tissues, the DBE will be better positioned to face current and future challenges of the Biomaterials field, and to sustain IST’s leadership and international recognition in this area.The new faculty hire is expected to emphasize one of the three key areas of stem cell culture engineering, organs-on-a-chip, or biomaterials with an emphasis on the interface between the biomaterial and the living cells and tissues.  More specifically, we are looking at one of the following three profiles: (i) bioreactor design and operation for stem cell expansion; (ii) advanced, integrated organ-on-chip devices for personalized medicine; or (iii) detailed characterization of the interface between biomaterials and the living cell tissues. These topics aim at boosting applications in cellular and gene therapy, tissue engineering and regenerative medicine, high-throughput drug screening, toxicological testing, and the development of cellular agriculture. Such interdisciplinary approaches will contribute to the development of advanced biomaterial systems and will be complementary to the existing expertise in the BNMR scientific area and in the DBE, contributing to achieving critical mass in the advanced biomaterials field of research. In addition, this faculty hire will contribute to related course topics offered by DBE at BSc., MSc. and PhD levels in the fields of Biological Engineering, Biomedical Engineering, Biotechnology and Regenerative and Precision Medicine which include, but are not limited to, areas of cell and tissue engineering, organ engineering, bioMEMS and biomaterials.The ideal candidate is expected to establish a nationally and internationally recognized independent research program (evidenced by publications and capture of external funding) that increases the impact and visibility of IST and iBB in the area. She/he should lead/launch/strengthen the BNMR area with a focus on stem cell culture engineering, organs-on-a-chip, or biomaterials with an emphasis on the interface between the biomaterial and the living cells and tissues; complement existing research lines in the DBE and in iBB; create new teaching offerings or enhance existing ones; and teach and work collaboratively on academic courses both at undergraduate and graduate.In line with the policy of the Scientific Council of IST, the DBE and iBB will carry out an extensive search process to obtain evidence of the existence of potential candidates with a profile suitable for filling the position. This scouting process entails actively promoting our search for specific profiles and inviting potential candidates to conduct seminars or interviews at IST.

Beneficiaries

Within the scope of the Recovery and Resilience Plan, two types of beneficiaries are responsible for carrying out the projects and using the funding provided. Due to their similar role, the reference to these two types of beneficiaries has been simplified and unified under the term "Beneficiary".
The two types are::
  • Direct Beneficiaries are those whose funding and projects to implement are part of the Recovery and Resilience Plan that has been negotiated and approved by the European Union;
  • Final Beneficiaries are those whose funding and projects to implement are approved following a selection process through Calls for Applications.

Call for applications

As part of the Call for Applications, submissions are requested to select the projects and final beneficiaries to whom funding will be awarded. Specific selection criteria are defined for each call, which must be reflected in the applications submitted and assessed.

The project is appraised on the basis of its compliance with the selection criteria laid down in the calls for applications, and a final score may be awarded, where applicable.

Final evaluation score

9,5
Important note

The components for calculating the assessment score can be found in the selection criteria document mentioned below.

Selection criteria

The funding selection criteria to which this project and its final beneficiary were subject and its score can be found in detail on the Recuperar Portugal platform.

Beneficiaries

Intermediate beneficiaries

Beneficiaries

Procurement

Beneficiaries representing public entities implement their project by signing one or more contracts with suppliers for goods or services through public procurement procedures.

To ensure and provide the utmost transparency in all these contracts, a list of the contracts that were signed under this project is available here, along with the information available on the Base.Gov platform. Please note that, according to the legislation in force at the time the contract was signed, some exceptions do not require the publication of the contracts signed on this platform, and, therefore, no information is available in such cases.

Geographic distribution

123,39 thousand €

Total amount of the project

Where was the money spent

By county

1 county financed .

  • Lisboa 123,39 thousand € ,
Source EMRP
10.02.2026
All themes
Transparency without leading